These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25917215)

  • 1. Rat precision-cut intestinal slices to study P-gp activity and the potency of its inhibitors ex vivo.
    Li M; de Graaf IA; de Jager MH; Groothuis GM
    Toxicol In Vitro; 2015 Aug; 29(5):1070-8. PubMed ID: 25917215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-gp activity and inhibition in the different regions of human intestine ex vivo.
    Li M; de Graaf IA; de Jager MH; Groothuis GM
    Biopharm Drug Dispos; 2017 Mar; 38(2):127-138. PubMed ID: 27757966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo.
    Li M; de Graaf IA; van de Steeg E; de Jager MH; Groothuis GM
    Toxicol In Vitro; 2017 Apr; 40():26-33. PubMed ID: 27939799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Consequence of Drug-Drug Interactions Influencing the Interplay between P-Glycoprotein and Cytochrome P450 3a: An Ex Vivo Study with Rat Precision-Cut Intestinal Slices.
    Li M; de Graaf IA; Siissalo S; de Jager MH; van Dam A; Groothuis GM
    Drug Metab Dispos; 2016 May; 44(5):683-91. PubMed ID: 26932816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetaminophen inhibits intestinal p-glycoprotein transport activity.
    Novak A; Carpini GD; Ruiz ML; Luquita MG; Rubio MC; Mottino AD; Ghanem CI
    J Pharm Sci; 2013 Oct; 102(10):3830-7. PubMed ID: 23897240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
    Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related differences on P-glycoprotein-mediated drug intestinal transport in rats.
    Mariana B; Adrián L; Guillermo V; Juan S; Laura M; Carlos L
    J Pharm Pharmacol; 2011 May; 63(5):619-26. PubMed ID: 21492163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
    Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
    González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
    Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123.
    Pavek P; Staud F; Fendrich Z; Sklenarova H; Libra A; Novotna M; Kopecky M; Nobilis M; Semecky V
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1239-50. PubMed ID: 12626638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin.
    Huo X; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):420-8. PubMed ID: 23981338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A.
    Johnson BM; Charman WN; Porter CJ
    Drug Metab Dispos; 2003 Sep; 31(9):1151-60. PubMed ID: 12920171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro predictability of drug-drug interaction likelihood of P-glycoprotein-mediated efflux of dabigatran etexilate based on [I]2/IC50 threshold.
    Kishimoto W; Ishiguro N; Ludwig-Schwellinger E; Ebner T; Schaefer O
    Drug Metab Dispos; 2014 Feb; 42(2):257-63. PubMed ID: 24212378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function.
    Parasrampuria DA; Lantz MV; Benet LZ
    Pharm Res; 2001 Jan; 18(1):39-44. PubMed ID: 11336351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-mediated uptake of rhodamine 123: implications on its use for MDR research.
    Cho CW; Liu Y; Yan X; Henthorn T; Ng KY
    Biochem Biophys Res Commun; 2000 Dec; 279(1):124-30. PubMed ID: 11112427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
    Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
    Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats.
    Yigitaslan S; Erol K; Cengelli C
    Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.